Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 3, 2013, Pages 521-530

  Peng, Yanfei ^a   Shi, Jiandang ^a   Du, Xiaoling ^a   Wang, Liang ^a   Klocker, Helmut ^b   Mo, Linjian ^c   Mo, Zengnan ^c   Zhang, Ju ^a  

^a NANKAI UNIVERSITY   (China)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Metastasis; Prostaglandin E2; Prostate cancer; Stromal cell derived factor 1; Stromal epithelial interaction

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; N [(5 BROMO 2 METHOXYPHENYL)SULFONYL] 3 [2 (2 NAPHTHYLMETHYL)PHENYL]ACRYLAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NEUTRALIZING ANTIBODY; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E2; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1; SULPROSTONE; TRANSCRIPTION FACTOR SP1;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; MALE; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; STROMA CELL; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; EPITHELIAL CELLS; HUMANS; MALE; NEOPLASM METASTASIS; PROMOTER REGIONS, GENETIC; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; STROMAL CELLS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84873363617     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.11.017     Document Type: Article

References (38)

1. P. Abedinpour, V.T. Baron, J. Welsh, and P. Borgstrom Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo Prostate 71 2011 813 823
2. M. Ao, O.E. Franco, D. Park, D. Raman, K. Williams, and S.W. Hayward Cross-talk between paracrine-Acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium Cancer Research 67 2007 4244 4253
3. M. Arya, H.R. Patel, C. McGurk, R. Tatoud, H. Klocker, and J. Masters The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis Journal of Experimental Therapeutics and Oncology 4 2004 291 303
4. L. Begley, C. Monteleon, R.B. Shah, J.W. Macdonald, and J.A. Macoska CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro Aging Cell 4 2005 291 298
5. M. Bilak, L. Wu, Q. Wang, N. Haughey, K. Conant, and C. St Hillaire PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis Annals of Neurology 56 2004 240 248
6. Y. Cai, Y.F. Lee, G. Li, S. Liu, B.Y. Bao, and J. Huang A new prostate cancer therapeutic approach: combination of androgen ablation with COX-2 inhibitor International Journal of Cancer 123 2008 195 201
7. A.A. Chaudry, K.W. Wahle, S. McClinton, and L.E. Moffat Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors International Journal of Cancer 57 1994 176 180
8. E.P. Chen, and E.M. Smyth COX-2 and PGE2-dependent immunomodulation in breast cancer Prostaglandins & Other Lipid Mediators 96 2011 14 20
9. S.R. Chinni, S. Sivalogan, Z. Dong, J.C. Filho, X. Deng, and R.D. Bonfil CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-Associated CXCL12 Prostate 66 2006 32 48
10. T. Cordes, F. Hoellen, C. Dittmer, D. Salehin, S. Kummel, and M. Friedrich Correlation of prostaglandin metabolizing enzymes and serum PGE2 levels with vitamin D receptor and serum 25(OH)2D3 levels in breast and ovarian cancer Anticancer Research 32 2012 351 357
11. J. Edwards, R. Mukherjee, A.F. Munro, A.C. Wells, A. Almushatat, and J.M. Bartlett HER2 and COX2 expression in human prostate cancer European Journal of Cancer 40 2004 50 55
12. C. Garcia-Moruja, J.M. Alonso-Lobo, P. Rueda, C. Torres, N. Gonzalez, and M. Bermejo Functional characterization of SDF-1 proximal promoter Journal of Molecular Biology 348 2005 43 62
13. N. Hatae Cooperation of two subtypes of PGE2 receptor, Gi coupled EP3 and Gs coupled EP2 or EP4 subtype Yakugaku Zasshi 123 2003 837 843
14. N. Hatae, A. Kita, S. Tanaka, Y. Sugimoto, and A. Ichikawa Induction of adherent activity in mastocytoma P-815 cells by the cooperation of two prostaglandin E2 receptor subtypes, EP3 and EP4 Journal of Biological Chemistry 278 2003 17977 17981
15. W.H. Hsu, C.N. Chen, H.I. Huang, Y.L. Lai, C.Y. Teng, and W.H. Kuo Urokinase induces stromal cell-derived factor-1 expression in human hepatocellular carcinoma cells Journal of Cellular Physiology 227 2012 697 704
16. H. Katoh, K. Hosono, Y. Ito, T. Suzuki, Y. Ogawa, and H. Kubo COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems American Journal of Pathology 176 2010 1469 1483
17. H.N. Kim, N.K. Narayanan, S. Lasano, and B. Narayanan Modulation of PGE2-induced EP4 expression on snail signaling and the impact on epithelial-mesenchymal transition: significance of EP4 antagonism Anticancer Research 31 2011 4347 4357
18. S. Li, and M.F. Wilkinson Site-directed mutagenesis: a two-step method using PCR and DpnI Biotechniques 23 1997 588 590
19. L. Liu, C. Liu, F. Lou, G. Zhang, X. Wang, and Y. Fan Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells Journal of Pathology 225 2011 203 211
20. S. Madar, R. Brosh, Y. Buganim, O. Ezra, I. Goldstein, and H. Solomon Modulated expression of WFDC1 during carcinogenesis and cellular senescence Carcinogenesis 30 2009 20 27
21. L. Miao, J. Shi, C.Y. Wang, Y. Zhu, X. Du, and H. Jiao Estrogen receptor-related receptor alpha mediates up-regulation of aromatase expression by prostaglandin E2 in prostate stromal cells Molecular Endocrinology 24 2010 1175 1186
22. Y. Miyata, S. Kanda, S. Maruta, T. Matsuo, H. Sakai, and T. Hayashi Relationship between prostaglandin E2 receptors and clinicopathologic features in human prostate cancer tissue Urology 68 2006 1360 1365
23. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiological Reviews 79 1999 1193 1226
24. N. Obermajer, R. Muthuswamy, K. Odunsi, R.P. Edwards, and P. Kalinski PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment Cancer Research 71 2011 7463 7470
25. X. Qian, J. Zhang, and J. Liu Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway Journal of Biological Chemistry 286 2011 2111 2120
26. E. Richardsen, R.D. Uglehus, J. Due, C. Busch, and L.T. Busund COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67 Cancer Epidemiology 34 2010 316 322
27. S. Singh, U.P. Singh, W.E. Grizzle, and J.W. Lillard Jr. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion Laboratory Investigation 84 2004 1666 1676
28. P. Sooriakumaran, H.M. Coley, S.B. Fox, P. Macanas-Pirard, D.P. Lovell, and A. Henderson A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer Anticancer Research 29 2009 1483 1488
29. Y.X. Sun, A. Schneider, Y. Jung, J. Wang, J. Dai, and K. Cook Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo Journal of Bone and Mineral Research 20 2005 318 329
30. M.L. Sung, C.C. Wu, H.I. Chang, C.K. Yen, H.J. Chen, and J.C. Cheng Shear stress inhibits homocysteine-induced stromal cell-derived factor-1 expression in endothelial cells Circulation Research 105 2009 755 763
31. P. Uotila, E. Valve, P. Martikainen, M. Nevalainen, M. Nurmi, and P. Harkonen Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer Urological Research 29 2001 23 28
32. B. Walter, S. Rogenhofer, M. Vogelhuber, A. Berand, W.F. Wieland, and R. Andreesen Modular therapy approach in metastatic castration-refractory prostate cancer World Journal of Urology 28 2010 745 750
33. C.Y. Wang, J.D. Shi, C.H. Yan, Q. Wu, H. Klocker, and I. Park Development of a cell-isolation method for human prostatic smooth muscle cells based on cell type-specific activation of the SM22 gene promoter British Journal of Urology International 99 2007 183 188
34. W. Wang, A. Bergh, and J.E. Damber Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer Clinical Cancer Research 11 2005 3250 3256
35. K.E. White, Q. Ding, B.B. Moore, M. Peters-Golden, L.B. Ware, and M.A. Matthay Prostaglandin E2 mediates IL-1beta-related fibroblast mitogenic effects in acute lung injury through differential utilization of prostanoid receptors Journal of Immunology 180 2008 637 646
36. Q. Wu, Y. Zhou, L. Chen, J. Shi, C.Y. Wang, and L. Miao Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2 Journal of Endocrinology 195 2007 89 94
37. S. Zhang, L. Qi, M. Li, D. Zhang, S. Xu, and N. Wang Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer Journal of Experimental & Clinical Cancer Research 27 2008 62
38. Z. Zhang, L. Wang, M. Mei, Y. Zhu, X. Du, and C. Lee Both nongenomic and genomic effects are involved in estradiol's enhancing the phenotype of smooth muscle cells in cultured prostate stromal cells Prostate 70 2010 317 332